Skip to Main Content

Paper Details

Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine.
Vaccines (Basel)
2
2023
OMVs, Omicron BA, Outer membrane vesicles, RBM, RBM ancestral, SARS, SARS-, SARS-CoV, SARS-CoV-, SARS-CoV-2, bacterial, mice, spike protein
Author NameAffiliation
Walther MothesYale University
Walther MothesYale University
Pradeep D UchilYale University
Pradeep D UchilYale University
Martino BolognesiUniversity of Milan
  • 1 - 5

Datasets

Release 1.2